Insider · CIK 0001689394
Michael Catelani
Files at ANIX (Anixa Biosciences Inc). First filing Jan 15, 2025, latest Sep 30, 2026.
Michael Catelani files SEC Form 4 as CFO, COO and president at ANIX (Anixa Biosciences Inc). Since Jan 15, 2025, Michael Catelani has reported 2 open-market buys worth $36k and 0 open-market sells worth $0, the latest filed on Sep 30, 2026.
A track record needs three past buys with six months of prices behind them; Michael Catelani has 0, so none is measured yet.
The newest scored trade: bought $16k of ANIX on Sep 30, 2026, filed Sep 30, 2026, scored 40 (moderate). In the last 12 months: 1 buy worth $16k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIX: Anixa Biosciences Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Anixa Biosciences Inc | $16k 5,500 shares | +12% | - | |
| 43Moderate | Anixa Biosciences Inc | $20k 9,289 shares | +26% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,500 | $2.84 | $16k | 50,000 | 13 d ago |
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +175,000 | $0.00 | $0 | 175,000 | Jan 6, 2026 |
| Jan 15, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +9,289 | $2.15 | $20k | 44,500 | Jan 15, 2025 |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +350,000 | $0.00 | $0 | 350,000 | Jan 3, 2025 |
Questions about Michael Catelani
Answered from the filings on this page, as of the latest one.
Is Michael Catelani buying or selling?
In the last 12 months Michael Catelani reported 1 open-market buy worth $16k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $16k of ANIX on Sep 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael Catelani's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Catelani has 0.
Where does Michael Catelani file Form 4?
Michael Catelani has filed Form 4 at ANIX (Anixa Biosciences Inc) as President, COO & CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.